BroadVision Announces Third Quarter 2016 Results
Nov 09, 2016 21:30 pm UTC| Business
REDWOOD CITY, Calif., Nov. 09, 2016 -- BroadVision, Inc. (NASDAQ:BVSN), a leading provider of e-business and engagement management solutions, today reported financial results for its third quarter ended September 30,...
Flywire Expands Cross-Border Tuition Payment Service in Australia
Nov 09, 2016 21:30 pm UTC| Business
SYDNEY, Australia, Nov. 09, 2016 -- Flywire, a leading provider of cross-border payment solutions, has expanded in Australia, opening a new office in Sydney to support its local operations. The move builds on Flywire’s...
Esperion Therapeutics to Present at the Stifel 2016 Healthcare Conference
Nov 09, 2016 21:30 pm UTC| Business
Presentation and Webcast on Wednesday, November 16, 2016 at 3:00 p.m. Eastern Time ANN ARBOR, Mich., Nov. 09, 2016 -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), a pharmaceutical company focused on developing and...
Alphatec Holdings Announces Third Quarter 2016 Revenue and Financial Results
Nov 09, 2016 21:29 pm UTC| Business
CARLSBAD, Calif., Nov. 09, 2016 -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, announced today financial results for the third quarter...
FutureFuel Releases Third Quarter and Nine-Month 2016 Results
Nov 09, 2016 21:29 pm UTC| Business
FutureFuel Third Quarter Net Income Increases 165% or $8 Million Reports Net Income of $12.9 Million or $0.29 per Diluted Share, and Adjusted EBITDA of $10.1 Million CLAYTON, Mo., Nov. 09, 2016 -- FutureFuel Corp....
Avid Announces Third Quarter 2016 Results
Nov 09, 2016 21:26 pm UTC| Business
Continued Strong Growth in Cloud-Enabled SubscriptionsEfficiency Program and Completion of Transformation in Q2 2017 On-TrackFull-Year Guidance Updated to Reflect Transition of Storage Product and Continued Enterprise...
Nov 09, 2016 21:20 pm UTC| Business
CORAL GABLES, Fla., Nov. 09, 2016 -- Catalyst Pharmaceuticals, Inc.(Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating...